Lauren Marcath
Assistant Professor, Pharmacotherapy 509-368-6697 HSB 215D Spokane


Doctor of Pharmacy, University of Michigan College of Pharmacy

Fellowships & Additional Training

Post-Doctoral Fellowship in Clinical Translational Pharmaceutical Sciences, Department of Clinical Pharmacy, University of Michigan College of Pharmacy


Co-instructor of record for the following courses:

  • P507: Top 200 Drugs
  • P516: Health Care Systems

Research or Practice Site

My research interests include pharmacogenetics and drug-drug interactions.

Selected Publications

Marcath LA, Kidwell KM, Robinson A, Vangipuram K, Burness ML, Griggs JJ, Van Poznak CV, Schott AF, Hayes DF, Henry NL, Hertz DL. Patients carrying CYP2C8*3 have shorter systemic paclitaxel exposure. Pharmacogenomics. 2018.

Marcath LA, Coe TD, Hoylman EK, Redman BG, Hertz DL. (2018). Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials. BMC Cancer. 2018; 18(1):1155.

Marcath LA, Xi J, Hoylman EK, Kidwell KM, Kraft SL, Hertz DL. Comparison of nine tools for screening drug-drug interactions of oral oncolytics. Journal of Oncology Practice. 2018; 14(6):e368-e374.

Marcath LA, Deal AM, Van Wieren E, Danko W, Walko CM, Ibrahim JG, Weck KE, Jones DR, Desta Z, McLeod HL, Carey LA, Irvin Jr. WJ, Hertz DL. Comprehensive assessment of cytochromes P450 and transporter genetics with endoxifen concentration during tamoxifen treatment. Pharmacogenetics and Genomics. 2017;27(11):402-409.